Murray Stewart
Director/Board Member at X4 PHARMACEUTICALS, INC.
Net worth: 193 419 $ as of 30/05/2024
Murray Stewart active positions
Companies | Position | Start | End |
---|---|---|---|
X4 PHARMACEUTICALS, INC. | Director/Board Member | 28/03/2019 | - |
Chief Tech/Sci/R&D Officer | 28/11/2022 | 31/07/2023 | |
Vivli Center For Global Clinical Research Data | Director/Board Member | - | - |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Director/Board Member | - | - |
Career history of Murray Stewart
Former positions of Murray Stewart
Companies | Position | Start | End |
---|---|---|---|
VECTIVBIO HOLDING AG | Director/Board Member | 01/09/2021 | 25/06/2023 |
Independent Dir/Board Member | 01/09/2021 | 25/06/2023 | |
AMARIN CORPORATION PLC | Director/Board Member | 09/01/2023 | 05/03/2023 |
Independent Dir/Board Member | 09/01/2023 | 05/03/2023 | |
RHYTHM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 14/10/2018 | 09/09/2021 |
NOVELION THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 26/11/2017 | 16/10/2018 |
GSK PLC | Chief Tech/Sci/R&D Officer | 31/03/2014 | 31/10/2017 |
Corporate Officer/Principal | - | - |
Training of Murray Stewart
The University of Southampton | Doctorate Degree |
Statistics
International
United States | 4 |
United Kingdom | 3 |
Switzerland | 3 |
Operational
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Independent Dir/Board Member | 2 |
Sectoral
Health Technology | 8 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
GSK PLC | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
X4 PHARMACEUTICALS, INC. | Health Technology |
AMARIN CORPORATION PLC | Health Technology |
Private companies | 4 |
---|---|
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Vivli Center For Global Clinical Research Data | |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Murray Stewart
- Experience